TrialFind
Saved trials
Back to results
Completed
Phase 3
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250601
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Administrative Office
Bridgewater, New Jersey, United States
View on ClinicalTrials.gov
Official details
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression — TrialFind